乳腺癌是影響全球婦女的最常見、最令人擔(dān)憂的疾病之一。許多正在進(jìn)行的研究都集中在乳腺癌診斷技術(shù)的開發(fā)上,以識(shí)別乳腺腫瘤并確定其特征,從而使醫(yī)護(hù)人員能夠確定癌癥的分期和類型,并指導(dǎo)治療決策。在這篇博文中,我們將探討乳腺癌研究的最新進(jìn)展,重點(diǎn)是SCIENION的精密噴點(diǎn)技術(shù)對(duì)乳腺癌診斷和治療創(chuàng)新的影響。

基因組剖析
乳腺癌研究領(lǐng)域最重要的突破之一是利用基因組剖析技術(shù)更好地了解腫瘤的基因狀況。基因組圖譜分析通過分析癌細(xì)胞的DNA來確定驅(qū)動(dòng)腫瘤生長的特定基因突變或改變。基因組圖譜分析方法采用下一代測(cè)序技術(shù)（NGS），這需要精確處理液體以創(chuàng)建測(cè)序文庫。SCIENION 的 sciFLEXARRAYER 精密微量點(diǎn)樣儀以及 Cellenion的單細(xì)胞分選和納升噴點(diǎn)解決方案,cellenONE使DLP+1可擴(kuò)展單細(xì)胞全基因組測(cè)序平臺(tái)的開發(fā)成為可能,該平臺(tái)在預(yù)測(cè)癌癥演變和耐藥性方面展現(xiàn)出巨大潛力。通過基因組分析獲得的信息可以制定更精確、更個(gè)性化的治療方案，因?yàn)槟承┗�因突變�?duì)靶向療法的反應(yīng)更好�；�因組分析還能識(shí)別乳腺癌高危人群，從而采取積極的預(yù)防措施。
 

sciFLEXARRAYER

1. Laks, Emma, et al. “Resource: Scalable whole genome sequencing of 40,000 single cells identifies stochastic aneuploidies, genome replication states and clonal repertoires.” BioRxiv(2018): 411058.

2. Salehi, Sohrab, et al. “Clonal fitness inferred from time-series modelling of single-cell cancer genomes.” Nature7868 (2021): 585-590.

3. Joh, Daniel Y., et al. “Cellphone enabled point-of-care assessment of breast tumor cytology and molecular HER2 expression from fine-needle aspirates.” NPJ Breast Cancer1 (2021): 85.

4. Jahani, Yasaman, et al. “Imaging-based spectrometer-less optofluidic biosensors based on dielectric metasurfaces for detecting extracellular vesicles.” Nature Communications1 (2021): 3246.

5. Allelein, Susann, et al. “Potential and challenges of specifically isolating extracellular vesicles from heterogeneous populations.” Scientific Reports1 (2021): 11585.

6. Lustig, Marta, et al. “Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells.” Frontiers in Immunology14 (2023): 1178817.

7. Khilji, Sana Khan, et al. “Generation of glycan-specific nanobodies.” Cell Chemical Biology8 (2022): 1353-1361.